As US lawmakers inch closer to lifting the onerous restrictions on research into medicinal cannabis, the need for interdisciplinary collaboration between the pharmaceutical and cannabis industries has never been clearer, or more essential. Canna Pharma 2022 will feature a two-track program devoted to non-pharmaceutical (or nutraceutical) cannabis product development, safety testing, quality control, and regulatory compliance (Day One) AND expanded, in-depth coverage of cannabinoid-derived pharmaceutical development and the regulatory expectations for novel cannabis-based pharmaceutical products (Day Two). Canna Pharma 2022, in partnership with Ethicann Pharmaceuticals, will also provide an expert how-to workshop on winning FDA & Health Canada approval for novel cannabinoid-based drug candidates. Join pre-clinical and clinical research scientists, product developers, cannabis cultivators, processors, and quality assurance professionals, who will come together this October to advance the science of medicinal cannabis. Register today to lock in your discounted rate for the two-day conference, or contact Kim (khubbard@pharmaedresources.com) for group, single-day, and/or workshop rates.